Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Fluidigm Teams Up With SABiosciences

Fluidigm and SABiosciences (a Qiagen company) have teamed up to create over 100 pathway-focused gene expression panels validated for real-time PCR analysis on the Fluidigm BioMark System for Genetic Analysis. The kits are named as the RT Profiler PCR Arrays for the Fluidigm BioMark system.

The gene expression assays are specifically designed for the workflow of Fluidigm’s integrated fluidic circuits (IFCs) and the BioMark system. Each reagent kit includes pre-aliquoted reagents and primers needed for synthesizing first-strand cDNA ready for preamplification and pathway-focused analysis.

PCR Arrays contain enough reagent to run five 96.96 Dynamic Array chips (customized panels are also available). PCR arrays come in a 96-well format making either 96.96 or 48.48 Dynamic Array chip set up fast, simple and affordable.

PCR arrays are increasingly being used in research on cancer, immunology, stem cells, toxicology, biomarker discovery and validation, and phenotypic analysis of cells and transgenic animals.

Mike Lee, senior director of marketing at Fluidigm, said: “SABiosciences solutions focusing on the analysis of pathways with real time assay panel kits are an excellent fit to our products. The kits include 96 cataloged gene expression assays, targeting genes in signal transduction, biological process, and disease-related pathways. The kits can provide a great solution for customers looking to lower start up costs, or that need pre-validated pathways for a new project.”

Shankar Sellappan, product manager of PCR Array at SABiosciences, said: “SABiosciences offers real-time PCR Arrays that are the most reliable and sensitive gene expression profiling technology for analyzing a focused panel of genes and now gain the additional benefits of Fluidigm’s genetic analysis technology.”

Fluidigm develops, manufactures and markets Integrated Fluidic Circuit (IFC) systems that improve productivity in life science research. Fluidigm’s IFCs enable the simultaneous performance of thousands of sophisticated biochemical measurements in minute volumes.